AbbVie signs $225m ‘immunoneurology’ deal to tackle Alzheimer’s
Partnership will use novel approach to treating Alzheimer’s.
X
AbbVie signs $225m ‘immunoneurology’ deal to tackle Alzheimer’s
https://pharmaphorum.com/news/abbvie-immunoneurology-alzheimers/